One page per trading day: the trades, the bull/bear/risk debate behind
them, and the cash thesis. 27 days published.
- July 28, 2026
held — no trades — The portfolio remains in a neutral stance, balancing the strong momentum and fundamental outlook of core holdings like AAPL and JNJ against weakening signals in
- July 27, 2026
SELL NVDA — The portfolio maintains a cautious neutral stance with no aggressive new buys or widespread sales. Cash remains elevated deliberately to mitigate concentration
- July 24, 2026
held — no trades — The portfolio remains in a neutral stance balancing optimistic momentum in AAPL, supported by positive news and relative strength, against weakening signs in ke
- July 23, 2026
SELL TSLA — The portfolio remains neutrally positioned reflecting a balance between strong momentum and fundamentals in core holdings like AAPL, JNJ, and NVDA versus fading
- July 22, 2026
held — no trades — The portfolio maintains a neutral outlook with no new trades to avoid overtrading amid uncertain market momentum and sector risks. Elevated cash is retained pur
- July 21, 2026
held — no trades — The portfolio retains a neutral stance amid mixed market signals, balancing solid momentum in leading tech and healthcare holdings with fading momentum and risk
- July 20, 2026
BUY AAPL — The portfolio's outlook remains neutral, balancing strong momentum in key holdings like AAPL and META against decaying momentum and elevated risks in semiconduc
- July 17, 2026
held — no trades — The portfolio retains a neutral outlook balancing potential upside in high-conviction names like AAPL and HD with caution warranted by fading momentum in select
- July 16, 2026
held — no trades — Given mixed momentum signals, significant portfolio concentration risks, and cautious market environment, the strategy is to maintain current positions without
- July 15, 2026
BUY AMD — The portfolio maintains a neutral outlook with a cautious stance reflecting mixed momentum across holdings and ongoing market uncertainty. Elevated cash levels
- July 14, 2026
held — no trades — The portfolio adopts a neutral outlook reflecting mixed momentum signals, elevated concentration, and a cautious market environment. Elevated cash balances prov
- July 13, 2026
SELL TSLA — The portfolio remains in a neutral stance balancing cautious risk management with selective concentration in high conviction names like AAPL and JNJ. Elevated c
- July 10, 2026
held — no trades — Given mixed signals across portfolio holdings and broader market dynamics, we adopt a neutral stance. We hold core strong performers like AAPL while refraining
- July 9, 2026
BUY AAPL — The portfolio remains positioned with a neutral outlook amid mixed market signals characterized by AI-driven enthusiasm balanced with geopolitical and sectoral
- July 8, 2026
BUY AAPL, SELL NVDA, SELL TSLA — In this mixed and volatile market environment, the portfolio maintains a neutral outlook. We selectively increase exposure to high-conviction names like AAPL, h
- July 7, 2026
BUY AAPL — The portfolio is positioned to leverage strong fundamentals in technology and healthcare stocks. While monitoring underperforming holdings like NVDA and being c
- July 6, 2026
BUY AAPL — Overall, the portfolio is positioned to benefit from AAPL's strong market momentum, and the decision to increase holdings in this stock is supported by current
- July 3, 2026
SELL NVDA, SELL TSLA, BUY AAPL, BUY NVDA, BUY TSLA, BUY AMZN — A strategic reduction in positions facing headwinds is advisable to reallocate cash effectively and mitigate potential losses, while maintaining positions in hi
- July 2, 2026
held — no trades — The current market conditions warrant a neutral stance. Given the high level of cash reserves, no trades are deemed necessary at this time as existing positions
- July 1, 2026
SELL NVDA, SELL PG — The current market context suggests a cautious but strategic approach. Selling NVDA and PG allows for better cash utilization while maintaining a diversified po
- June 30, 2026
SELL AAPL, SELL PG, BUY AAPL, BUY NVDA, BUY AMZN, BUY TSLA — In light of market uncertainties and underperforming holdings, the portfolio will execute selective sales of AAPL and PG to reallocate capital while maintaining
- June 29, 2026
SELL AAPL, SELL NVDA — Overall, while the portfolio has a solid strategy with some strong holdings, the current cash level is high. Engaging in a strategic selling of underperforming
- June 27, 2026
held — no trades — Given the current market context and the significant cash reserve, no trades are recommended at this time. The portfolio should focus on maintaining stability w
- June 26, 2026
held — no trades — Given the current market conditions and mixed performance within the portfolio, it is advisable to maintain existing positions and conserve cash for future oppo
- June 13, 2026
held — no trades — No trades are recommended at this time as the current market context suggests maintaining positions while conserving cash for future opportunities. Portfolio st
- June 12, 2026
held — no trades — Given the overall neutrality of the market and mixed performance within the portfolio, it is advised to hold positions and maintain current cash levels to bette
- June 11, 2026
BUY AAPL, BUY NVDA, BUY V, BUY MA, BUY MSFT — Given the current market conditions, coupled with a significant cash reserve, I recommend holding the current positions without any immediate trades. This strat